Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emblem Corp EMMBF

"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Comment by christophwaltzon Oct 27, 2018 6:25pm
245 Views
Post# 28883004

RE:Emblem Cash Flow - Smart Value Investing

RE:Emblem Cash Flow - Smart Value InvestingThompson Reuters projects 2019 revenue between $34.1-$71.4M, and last quarterly expense she were $4M, which will of course trends up as well.

We don't know what their sale should of medical XR tabs, Capsules will be in Canada, not what the Canadian medical patient picture will look like a year from now (insurance, physician adoption, ?clinicla trials and DIN numbers). We don't know what sales of those items or the Oral Sprays will be in Germany, not their pricing. We don't even know what recreational sales will be in Canada for Symbl, nor how many other brands they will release.

How are you coming up with a projection?
<< Previous
Bullboard Posts
Next >>